Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Share Discount Widens on Bet Novartis to Sell Stake
Bloomberg
Tuesday, December 17, 2013 - 8:56am
tags:
Roche, Novartis
Sucampo initiates global Phase 3 clinical program of lubiprostone
The Fly on the Wall
Tuesday, December 17, 2013 - 8:55am
tags:
Sucampo, Lubiprostone, pediatric functional constipation
Targacept shares tank after drug developer stops work on drug after mid-stage study failure
Yahoo/AP
Tuesday, December 17, 2013 - 8:52am
tags:
Targacept, TC-5619, schizophrenia, Alzheimer's disease
Why Northwest Bio's DCVax Brain Tumor Vaccine Will Blow Up Just Like ImmunoCellular's ICT-107
TheStreet.com
Tuesday, December 17, 2013 - 8:50am
tags:
Northwest Biotherapeutics, DCVax, ICT-107, glioblastoma multiforme
The Best Biotech CEO of 2013 is...
TheStreet.com
Tuesday, December 17, 2013 - 8:49am
tags:
biotech, Celgene, NPS Pharmaceuticals, Bristol-Myers Squibb, ONYX Pharmaceuticals
The Worst Biotech CEO of 2013 Is...
TheStreet.com
Tuesday, December 17, 2013 - 8:48am
tags:
biotech, Vical, Ariad Pharma, Aveo Oncology, Dendreon, Amarin
Arena's Belviq At The 6 Month Mark
Seeking Alpha
Tuesday, December 17, 2013 - 8:46am
tags:
Arena Pharmaceuticals, Belviq, obesity, Eisai
Why GSK sales shift is a turning-point for pharma
CNBC
Tuesday, December 17, 2013 - 7:02am
tags:
GSK, physician payments, drug reps
GSK to stop paying doctors to promote drugs, and will no longer link sales rep pay to Rx data
Reuters
Monday, December 16, 2013 - 10:00pm
tags:
GSK, drug reps, physician payments
More new drugs, yes. Lots more sales? Not always, thanks to skeptical payers
Fierce Pharma
Monday, December 16, 2013 - 9:57pm
tags:
drug sales
Pipeline Progress at Auxilium Pharma
Yahoo/Zacks.com
Monday, December 16, 2013 - 9:53pm
tags:
Auxilium, Xiaflex, frozen shoulder
Congressional Bill Would Restrict Pay-To-Delay Agreements
Pharmalot
Monday, December 16, 2013 - 2:19pm
tags:
pay-for-delay
Amarin CEO to Step Down; Replacement Named
Motley Fool
Monday, December 16, 2013 - 2:18pm
tags:
Amarin, Pharma CEOs, Joseph Zakrzewski
Possible New Lease On Life For Two Cardiology Drugs From Merck And J&J
Forbes
Monday, December 16, 2013 - 2:16pm
tags:
Merck, JNJ, Zontivity, Vorapaxar, Xarelto
Supreme Court refuses to hear ex-InterMune CEO's appeal
Yahoo/Reuters
Monday, December 16, 2013 - 2:14pm
tags:
Supreme Court, InterMune, Actimmune
Cubist antibiotic succeeds in late-stage trial, shares rise
Reuters
Monday, December 16, 2013 - 9:02am
tags:
ceftolozane/tazobactam, Cubist, antibiotics, intra-abdominal infections
J&J's combo diabetes drug held up by FDA
PM Live
Monday, December 16, 2013 - 8:29am
tags:
canagliflozin, diabetes, JNJ, metformin, FDA, Invokana
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Yahoo
Monday, December 16, 2013 - 8:24am
tags:
Valeant Pharmaceuticals, Solta Medical, devices, M&A
The Curious Case Of Questcor Pharmaceuticals
Seeking Alpha
Monday, December 16, 2013 - 8:22am
tags:
Questcor Pharmaceuticals, H.P. Acthar Gel
Opexa Therapeutics provides update on Phase IIb trial
Yahoo/Fly on the Wall
Monday, December 16, 2013 - 8:21am
tags:
Opexa, Tcelna, multiple sclerosis, MS

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.